Houston, TX -- (SBWIRE) -- 01/20/2018 -- Research N Reports offers latest published report "Chronic Low Back Pain Market - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2017-2025". The author of the report analyzed that the Global Chronic Low Back Pain Market accounted for US$ 5.89 billion in 2016.

Some of the leading players operating in the Global Chronic Low Back Pain Market include Stayble Therapeutics AB, Mesoblast INC, Axsome Therapeutics, INC, Norman Interventional Pain Management, Adynxx, INC.

Research N Reports brings key comprehensions on the subject of Global Chronic Low Back Pain Market in its latest report titled 'Chronic Low Back Pain Market by Diagnosis (X-Ray, Computerized Tomography (CT), Myelograms, Discography, MRI, Electrodiagnostics, Bone Scans, Ultrasound Imaging, Others); by Treatment (Analgesic Medications, Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Anticonvulsants, Antidepressants, Counter-irritants); by Surgery (Vertebroplasty and kyphoplasty, Spinal laminectomy, Discectomy or microdiscectomy, Foraminotomy, Intradiscal electrothermal therapy (IDET), Spinal fusion, Artificial disc replacement, Others); by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others); by Regions (North America, Europe, Asia-Pacific (APAC), Middle East & Africa and Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2017-2025.'

For Sample Copy of this report: https://www.researchnreports.com/request_sample.php?id=166267

Low back pain (LBP) is defined as a musculoskeletal pain, muscle tension, or stiffness localized below the bottom edge of the rib cage and above the gluteal sulcus, with or without sciatica, and is defined as chronic when it persists for 12 weeks or more. This pain may be caused by several diseases and disorders that affect the lumbar region of the spine. Low back pain can happen anywhere below the ribs and above the legs. Further, causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include prickly or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. The treatment includes pain medications such NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants.

Peruse the complete report titled "Chronic Low Back Pain Market - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2017-2025" at: https://www.researchnreports.com/pharma-healthcare/Chronic-Low-Back-Pain-Market-166267

The X-Ray segment is expected to hold the major share of the global market.

The radiographic assessments for low back pain involve the use of X-rays to identify the cause of the pain or discomfort. Furthermore, an MRI scan is commonly deliberated to be the single best imaging study of the spine to help plan treatment for back pain. The X-Ray segment is projected as the foremost segment, closely followed by MRI.

Analgesic medications segment is estimated to account as the leading segment during the prognosis period.

The analgesic medications segment is foreseen to lead the Global Chronic Low Back Pain Market, followed by Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) over the study period. The multidisciplinary pain rehabilitation treatment including analgesic medication withdrawal is associated with significant clinical improvements in physical and emotional functioning, regardless of surgical history of the lumbar spine. Furthermore, increasing use of emerging antidepressants will fuel growth of the chronic low back pain market.

Buy Complete report now at: https://www.researchnreports.com/checkout?id=166267

The spinal fusion segment is anticipated to grow at a robust pace

The spinal fusion segment is estimated to account for the leading share of the global market over the study period. Furthermore, it is expected that spinal fusion surgery will cure the patient of chronic low back pain and this is partly responsible for an exponential increase in rates of spinal fusion around the world. Spinal fusion is a major surgery which can be associated with significant morbidity and occasionally with mortality. Yet there is rapid rise in the rates of spinal fusion.

Hospitals segment is expected to be the largest segment of the global market.

On the basis of end user segmentation, the hospitals segment held a prevailing share in the past years and are predicted to attain sturdy growth during the forecast period. Furthermore, the increasing aging population, with an associated rise in the incidence of chronic low back pain, have also led to an increased demand for the global market.

North America registered the major share in the global market.

Regionally, the Global Chronic Low Back Pain Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Among these, North America accounted for the largest share of the global market. Furthermore, North America is predicted to play a crucial role in the market revenue as well. It plays an important role in the global market, and any slight changes occurring on behalf of the U.S. is likely to have a considerable effect on the global market.